Desjardins Global Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | $101K | Buy |
585
+109
| +23% | +$18.7K | 0.01% | 470 |
|
2023
Q3 | $70.4K | Sell |
476
-2,699
| -85% | -$399K | 0.01% | 508 |
|
2023
Q2 | $694K | Buy |
3,175
+594
| +23% | +$130K | 0.08% | 239 |
|
2023
Q1 | $565K | Buy |
2,581
+264
| +11% | +$57.8K | 0.07% | 225 |
|
2022
Q4 | $482K | Buy |
2,317
+117
| +5% | +$24.3K | 0.08% | 221 |
|
2022
Q3 | $480K | Sell |
2,200
-7
| -0.3% | -$1.53K | 0.06% | 232 |
|
2022
Q2 | $462K | Buy |
2,207
+131
| +6% | +$27.4K | 0.06% | 237 |
|
2022
Q1 | $503K | Buy |
2,076
+1
| +0% | +$242 | 0.04% | 261 |
|
2021
Q4 | $540K | Buy |
+2,075
| New | +$540K | 0.05% | 269 |
|